Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (5y) (2014 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.75% |
| Mar 31, 2026 | -14.73% |
| Dec 31, 2025 | 3.19% |
| Sep 30, 2025 | -2.97% |
| Jun 30, 2025 | -5.49% |
| Mar 31, 2025 | -4.42% |
| Dec 31, 2024 | -14.02% |
| Sep 30, 2024 | 3.65% |
| Jun 30, 2024 | -16.13% |
| Mar 31, 2024 | -11.94% |
| Dec 31, 2023 | 32.39% |
| Sep 30, 2023 | -11.92% |
| Jun 30, 2023 | -5.75% |
| Mar 31, 2023 | -29.50% |
| Dec 31, 2022 | -38.52% |
| Sep 30, 2022 | 7.17% |
| Jun 30, 2022 | 32.48% |
| Mar 31, 2022 | -36.14% |
| Dec 31, 2021 | -14.49% |
| Sep 30, 2021 | 14.97% |